ArticleTranslational pediatrics2026
Exploratory analysis of high-altitude effects on brain morphology and myelination in native Tibetan infants.
Article in Translational pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: High-altitude environments present unique challenges to brain adaptability. This study aimed to explore the brain magnetic resonance imaging (MRI) characteristics of neurologically normal Tibetan neonates, and to compare brain volumes and myelination status across different altitude levels. Methods: This was a case-control exploratory study. A total of 30 neurologically normal infants in the high-altitude group (altitude: 3,650 m) and a total of 30 neurologically normal infants in the sea-level group (altitude: 4 m) were included in the study. The infants in the two groups were matched 1:1 using propensity score matching (PSM) for gestational age at birth, birth weight, sex, and postnatal age at MRI examination. The primary outcomes were differences in volumetrically segmented tissue (lateral ventricles, gray matter, and white matter) and intracranial volume (ICV) between the two groups. We further compared the differences among altitude subgroups. Myelination status was also assessed using the T1-weighted/T2-weighted (T1w/T2w) ratio. Results: Compared with the sea-level group, ICV was significantly increased in the high-altitude group, an increase that appeared to be primarily attributable to larger gray matter and lateral ventricular volumes. The T1w/T2w ratio in the middle cerebellar peduncle (MCP) was significantly lower in the high-altitude group than the sea-level group. In the altitude subgroup analysis, ICV was found to be significantly increased in altitude subgroup 2 (4,000-4,800 m) but not in altitude subgroup 1 (3,500-4,000 m). Conclusions: ICV was significantly increased in the high-altitude group compared to the sea-level group, especially in altitude areas above 4,000 m. Additionally, delayed myelination in the MCP was observed in the high-altitude group.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.